HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday 23 March 2017

More NICE methods changes….

…on the back of their consultation reported in two posts in the HEDS blog last year (here and here).  The three key points:
  • Managed access if budget impact is over £20M in any of the first three years was approved.
  • Speedy appraisal and recommendations if the ICER looks to be under £10K.
  • The proposal to have a £100K threshold for (ultra?) orphan drugs got dropped.  In favour of a £300K threshold.  This is not a typo.
Image: Challenge by Conal Gallagher

More details here.